DEEP VENOUS THROMBOSIS
Clinical trials for DEEP VENOUS THROMBOSIS explained in plain language.
Never miss a new study
Get alerted when new DEEP VENOUS THROMBOSIS trials appear
Sign up with your email to follow new studies for DEEP VENOUS THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer clot study halted: new drug vs standard care
Disease control TerminatedThis study tested a new blood thinner called abelacimab against the standard drug apixaban in about 1,150 people with cancer who had a blood clot. The goal was to see which drug better prevented new clots and caused less bleeding. The study was stopped early, but the results may …
Matched conditions: DEEP VENOUS THROMBOSIS
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 02:41 UTC
-
New blood thinner tested for cancer patients with dangerous clots
Disease control TerminatedThis study tested a new blood thinner called abelacimab against the standard drug dalteparin in 417 adults with stomach, bowel, or urinary cancers who also had blood clots. The goal was to see which drug better prevented new clots and caused less bleeding. The study was stopped e…
Matched conditions: DEEP VENOUS THROMBOSIS
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC